| Name
|
Angiotensin II, Human
|
| Other Name
|
Hypertensin II; Angiotensin 2; ANG 2; Angiotensin II; ANG IIAngiotensin II human acetate
|
| Sequence (Single letter abbreviations)
|
DRVYIHPF
|
| Sequence（Three letter abbreviations）
|
{ASP}{ARG}{VAL}{TYR}{ILE}{HIS}{PRO}{PHE}
|
| Basic description
|
Angiotensin II (ANG II) is an important physiological effector of blood pressure and volume regulation through vasoconstriction, sodium uptake, the release of aldosterone, and the stimulation of thirst. Angiotensin II is mediated by its interaction with, Angiotensin II type 1 membrane receptors.
|
| Solubility
|
Soluble in water (25 mg/ml), clear, colorless.
|
| The molecular weight
|
1046.180
|
| Chemical formula
|
C50H71N13O12
|
| The purity
|
> 95%
|
| Storage conditions
|
Store at -20°C. Keep container tightly closed.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Inagaki K, et al. Involvement of Bone Morphogenetic Protein-6 in Differential Regulation of Aldosterone Production by Angiotensin II and Potassium in Human Adrenocortical Cells. Endocrinology. Mar 2006.
Goossens GH, et al. Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans. J. Physiol. Mar 2006; 571(Pt 2): 451-460.
Maczewski M, et al. Angiotensin II AT1 receptor density on blood platelets predicts early left ventricular remodelling in non-reperfused acute myocardial infarction in humans. Eur. J. Heart Fail. Mar2006; 8(2): 173-178.
|
Angiotensin II, Human
